Atlas Trials

Biomarkers for the Activity of Immune Checkpoint Inhibitor Therapy in Patients With Advanced Melanoma

Clinical trial NCT02673970 · UNKNOWN

Trial details

NCT number
NCT02673970
Sponsor
Universitair Ziekenhuis Brussel
Status
UNKNOWN
Study type
OBSERVATIONAL
Malignant Melanoma
Start date
2014-10-01
Primary completion
2025-09-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.